Infectious Diseases, Professor of Medicine
Verified email at
Cited by
Cited by
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
R AJ, C V, B T, V P, C S, van Lunzen J, C GM, E V, G AM, B A, A D, V P, ...
JAMA 316 (2), 171-81, 2016
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of …
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ...
The Lancet 393 (10189), 2428-2438, 2019
Antifungal drug resistance to azoles and polyenes
MM Canuto, FG Rodero
The Lancet infectious diseases 2 (9), 550-563, 2002
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 …
P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ...
The Lancet 393 (10167), 143-155, 2019
Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression
S Swindells, JF Andrade-Villanueva, GJ Richmond, G Rizzardini, ...
New England Journal of Medicine 382 (12), 1112-1123, 2020
Evaluation of the Immunochromatographic Binax NOW Assay for Detection of Streptococcus pneumoniae Urinary Antigen in a Prospective Study of Community …
F Gutiérrez, M Mar, JC Rodríguez, A Ayelo, B Soldán, L Cebrián, C Mirete, ...
Clinical Infectious Diseases 36 (3), 286-292, 2003
Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index
M Masia, F Gutierrez, C Shum, S Padilla, JC Navarro, E Flores, ...
Chest 128 (4), 2223-2229, 2005
Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring
F Gutiérrez, A Navarro, S Padilla, R Antón, M Masiá, J Borrás, ...
Clinical infectious diseases 41 (11), 1648-1653, 2005
The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens
F Gutiérrez, M Masiá, C Mirete, B Soldán, JC Rodríguez, S Padilla, ...
Journal of infection 53 (3), 166-174, 2006
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
E Martinez, M Larrousse, JM Llibre, F Gutierrez, M Saumoy, A Antela, ...
Aids 24 (11), 1697-1707, 2010
Dalbavancin in the treatment of different gram-positive infections: a real-life experience
E Bouza, M Valerio, A Soriano, L Morata, EG Carus, ...
International journal of antimicrobial agents 51 (4), 571-577, 2018
Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
E Martínez, PM D'Albuquerque, JM Llibre, F Gutierrez, D Podzamczer, ...
AIDS 26 (18), 2315-26, 2012
Antibody response to SARS-CoV-2 is associated with long-term clinical outcome in patients with COVID-19: a longitudinal study
J García-Abellán, S Padilla, M Fernández-González, JA García, V Agulló, ...
Journal of clinical immunology 41 (7), 1490-1501, 2021
Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain
F Gutiérrez, M Masia, JC Rodriguez, C Mirete, B Soldán, S Padilla, ...
Clinical microbiology and infection 11 (10), 788-800, 2005
Long-acting injectable cabotegravir+ rilpivirine for HIV maintenance therapy: week 48 pooled analysis of phase 3 ATLAS and FLAIR trials
G Rizzardini, ET Overton, C Orkin, S Swindells, K Arasteh, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 85 (4), 498-506, 2020
Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy
M Masiá, S Padilla, D Alvarez, JC Lopez, I Santos, V Soriano, ...
Aids 27 (2), 181-189, 2013
Lopinavir plasma concentrations and changes in lipid levels during salvage therapy with lopinavir/ritonavir-containing regimens
F Gutiérrez, S Padilla, A Navarro, M Masiá, I Hernández, J Ramos, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 33 (5), 594-600, 2003
A bibliometric analysis of tuberculosis research indexed in PubMed, 1997–2006
JM Ramos, S Padilla, M Masia, F Gutierrez
The International Journal of Tuberculosis and Lung Disease 12 (12), 1461-1468, 2008
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study
RK Lodwick, CA Sabin, K Porter, B Ledergerber, A Van Sighem, ...
The Lancet 376 (9738), 340-345, 2010
Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy
F Gutiérrez, S Padilla, M Masiá, JA Iribarren, S Moreno, P Viciana, ...
Current HIV research 6 (2), 100-107, 2008
The system can't perform the operation now. Try again later.
Articles 1–20